DaVita Inc.

DVA Healthcare Medical Care Facilities

DaVita Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.6 billion, up 6.46% from fiscal 2024.

Revenue
+4.62%
EPS
+67.0%
Free cash flow
−45.8%
Total debt
+5.07%

Quarter to September 2026, against a year earlier

194.43 1.77 +0.92%
Market cap
$12.3B
P/E
14.0×
Fwd P/E
13.0×
Dividend yield
—
F-score
6/9
Altman Z
1.49
Beneish M
−2.59
Dividend safety
n/a

DaVita Inc. (DVA) Return on equity

Alert me on Return on equity

DaVita Inc.'s return on equity over the twelve months to 30 September 2026 was −277.7%, down 7023.9 percentage points from fiscal 2025 (6,746.2%). Over the past ten years it has ranged from 3.62% (fiscal 2018) to 6,746.2% (fiscal 2025) — the current reading is the highest in ten years. That is below the Medical Care Facilities industry median of 5.03% and below the Healthcare sector median of −26.3%.

Return on equity, annual

Embed this chart

Annual newest first

Period Return on equity Change (points)
FY2025 6,746.2% 6,632.00
FY2024 114.2% 48.95
FY2023 65.2% 3.39
FY2022 61.9% (16.34)
FY2021 78.2% 38.37
FY2020 39.8% 13.78
FY2019 26.0% 22.42
FY2018 3.62% (10.01)
FY2017 13.6% (4.08)
FY2016 17.7% 12.54

Against its own ten years

Low 3.62% High 6,746.2%
Ten-year median 39.8%
Current reading's percentile 100

Return on equity against peers

What Return on equity is

ROE shows how much profit a company earns for its shareholders on the equity they have in the business.

Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)

The full definition of Return on equity →

More on DVA